US Broker Ratings

Quest Diagnostics (DGX) Stock Analysis: Exploring a 12.57% Upside Potential

Quest Diagnostics Incorporated (NYSE: DGX), a leader in the healthcare sector specializing in diagnostics and research, is drawing attention from investors due to its robust market..

Novo Nordisk A/S (NVO) Stock Analysis: Robust Revenue Growth and Attractive Dividend Yield

Novo Nordisk A/S (NYSE: NVO), a titan in the healthcare sector, particularly in the drug manufacturing industry, continues to stand out with its strong financial performance..

Medtronic plc (MDT) Stock Analysis: A 14.97% Potential Upside with Strong Dividend Appeal

Medtronic plc (NYSE: MDT), a titan in the medical devices industry, continues to command investor attention with its sizable market presence and robust product portfolio. As..

Eli Lilly and Company (LLY) Stock Analysis: Robust Revenue Growth and Strategic Partnerships Fuel Optimism

Eli Lilly and Company (NYSE: LLY), a titan in the healthcare sector, continues to captivate investor interest with its impressive market cap of $966.16 billion. This..

AbbVie Inc. (ABBV) Stock Analysis: Exploring a $406 Billion Healthcare Giant with a 6.39% Potential Upside

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, stands out with its robust market capitalization of $406.46 billion. Known for its innovative contributions to..

Danaher Corporation (DHR) Stock Analysis: Potential Upside and Analyst Ratings Highlight Investment Appeal

Danaher Corporation (NYSE: DHR), a prominent player in the Healthcare sector, particularly in the Diagnostics & Research industry, continues to capture investor interest with its robust..

Abbott Laboratories (ABT) Stock Analysis: Exploring a 15.69% Potential Upside with Strong Buy Ratings

Abbott Laboratories (NYSE: ABT) stands as a formidable entity in the healthcare sector, specifically within the medical devices industry. With a robust market capitalization of $217.28..

Stryker Corporation (SYK) Stock Analysis: Evaluating a 20.86% Upside in the Medical Devices Sector

Stryker Corporation (NYSE: SYK), a titan in the healthcare sector, is making waves in the medical devices industry with a robust market capitalization of $135.46 billion...

Thermo Fisher Scientific Inc (TMO) Stock Report: Analyst Ratings Highlight 10% Upside Potential

Thermo Fisher Scientific Inc. (NYSE: TMO), a titan in the healthcare sector, continues to cement its position as a leader in the diagnostics and research industry...

AstraZeneca PLC (AZN) Stock Analysis: A Promising 6.52% Upside Potential for Investors

AstraZeneca PLC (AZN) stands tall within the healthcare sector as a formidable player in the global pharmaceutical landscape. With a market capitalization of $288.04 billion, it..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: A Glimpse at the 16.90% Return on Equity and Future Prospects

Intuitive Surgical, Inc. (NASDAQ: ISRG), with its robust market capitalization of $207.13 billion, has long been a stalwart in the healthcare sector, particularly within the medical..

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a 46.91% Potential Upside in the Healthcare Sector

AngioDynamics, Inc. (ANGO), a prominent player in the medical technology sector, is capturing the attention of investors with its promising growth potential and a substantial upside..

MBX Biosciences, Inc. (MBX) Stock Analysis: Biotech’s 84% Upside Potential Beckons Investors

MBX Biosciences, Inc. (NASDAQ: MBX), a burgeoning player in the biotechnology sector, presents a compelling opportunity for investors with its cutting-edge focus on precision peptide therapies...

Myriad Genetics, Inc. (MYGN) Stock Analysis: Unveiling a 30% Potential Upside Amidst Industry Challenges

Investors with a keen interest in the healthcare sector, particularly in diagnostics and research, might find Myriad Genetics, Inc. (NASDAQ: MYGN) an intriguing candidate for their..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating the Upside and Risks in the Biotech Sector

Fortrea Holdings Inc. (FTRE) is a rising entity in the healthcare sector, specifically within the biotechnology industry. Headquartered in Durham, North Carolina, this contract research organization..

Prothena Corporation plc (PRTA) Stock Analysis: Biotechnology Innovator with 109.84% Potential Upside

Prothena Corporation plc (NASDAQ: PRTA), a prominent player in the biotechnology sector, offers an intriguing investment opportunity given its substantial growth potential and innovative research pipeline...

Standard BioTools Inc. (LAB) Stock Analysis: Navigating Challenges with a 5.44% Upside Potential

For investors seeking opportunities in the healthcare sector, Standard BioTools Inc. (NASDAQ: LAB) presents an intriguing yet challenging prospect. With its focus on providing innovative solutions..

Verastem, Inc. (VSTM) Stock Analysis: Unlocking a 103% Upside Potential in the Biotech Sector

Verastem, Inc. (NASDAQ: VSTM) has emerged as a compelling player in the biotechnology sector, drawing investor attention with its promising pipeline and significant upside potential. With..

Surmodics, Inc. (SRDX) Stock Analysis: Examining Challenges Amid Healthcare Sector Volatility

Surmodics, Inc. (NASDAQ: SRDX), a prominent player in the healthcare sector, particularly within the medical devices industry, presents a mixed picture for investors navigating the complex..

Bioventus Inc. (BVS) Stock Analysis: Uncovering a Potential 103% Upside in the Medical Devices Sector

Bioventus Inc. (NASDAQ: BVS), a prominent player in the healthcare sector, particularly in medical devices, presents an intriguing opportunity for investors seeking robust potential returns. With..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds